DNTH Dianthus Therapeutics, Inc.

Fundamentals / CIK 0001690585 / USD

Dianthus Therapeutics, Inc. reported $2.04M in revenue and a net loss of $202.1M for the fiscal year ended December 31, 2025 (down 67.3% year over year), with a -11592.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DNTH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$23.29M$11.64M$0-$152.3MFY 2016 Revenue: $0FY 2016 Net Income: -$9.43M2016FY 2017 Revenue: $0FY 2017 Net Income: -$35.49M2017FY 2018 Revenue: $0FY 2018 Net Income: -$57.52M2018FY 2019 Revenue: $0FY 2019 Net Income: -$76.77M2019FY 2020 Net Income: -$74.94M2020FY 2021 Net Income: -$71.14M2021FY 2022 Net Income: -$28.48M2022FY 2023 Revenue: $2.83MFY 2023 Net Income: -$43.55M2023FY 2024 Revenue: $6.24MFY 2024 Net Income: -$84.97M2024FY 2025 Revenue: $2.04MFY 2025 Net Income: -$162.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.04M $6.24M $2.83M -- -- -- $0 $0 $0 $0
Research & Development $145.6M $83.11M $32.84M $29.38M $46.77M $50.62M $59.21M $41.34M $27.90M $5.78M
Total Operating Expenses $180.0M $108.1M $51.00M $36.12M $74.69M $78.70M $82.97M $59.96M $35.73M $9.27M
Operating Income -$177.9M -$101.9M -$48.17M -$29.70M -$74.69M -$78.70M -$82.97M -$59.96M -$35.73M -$9.27M
EBITDA -$177.8M -$101.8M -$48.11M -$27.78M -$72.67M -$76.72M -$81.13M -$59.09M -$35.35M -$9.26M
Interest Income $9.96M $11.35M $3.34M $1.15M -- -- -- -- -- --
Interest Expense -- -- -- -- -- -- -- -- -- $163K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$162.3M -$84.97M -$43.55M -$28.48M -$71.14M -$74.94M -$76.77M -$57.52M -$35.49M -$9.43M
Basic EPS -$4.20 -$2.55 -$8.45 -$32.57 -$1.29 -$1.71 -$2.07 -$3.13 -$19.12 -$65.15
Diluted EPS -$4.20 -$2.55 -$8.45 -$32.57 -$1.29 -$1.71 -$2.07 -$3.13 -$19.12 -$65.15
Basic Shares Outstanding 38.6M 33.3M 5.2M 874.2K 54.9M 43.9M 37.0M 18.4M 1.9M 149.4K
Diluted Shares Outstanding 38.6M 33.3M 5.2M 874.2K 54.9M 43.9M 37.0M 18.4M 1.9M 149.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $284K $396K $193K $1.16M $1.33M
Research & Development $45.60M $48.69M $34.53M $59.90M $32.49M $26.25M $27.00M $26.41M
Total Operating Expenses $59.68M $62.24M $47.00M $69.83M $40.68M $35.12M $34.34M $33.24M
Operating Income -$58.47M -$61.48M -$46.53M -$69.54M -$40.29M -$34.93M -$33.18M -$31.92M
EBITDA -$58.44M -$61.45M -$46.50M -$69.51M -$40.26M -$34.90M -$33.15M -$31.89M
Interest Income $11.26M $5.89M $5.05M $4.41M $1.35M $2.31M $1.89M $1.25M
Net Income -$46.64M -$50.22M -$40.83M -$64.43M -$36.77M -$31.63M -$29.51M -$28.44M
Basic EPS -$0.81 -$0.90 -$0.85 -- -$0.97 -$0.88 -$0.82 --
Diluted EPS -$0.81 -$0.90 -$0.85 -- -$0.97 -$0.88 -$0.82 --
Basic Shares Outstanding 57.3M 56.0M 48.0M -- 37.8M 35.8M 35.8M --
Diluted Shares Outstanding 57.3M 56.0M 48.0M -- 37.8M 35.8M 35.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $51.09M $22.79M $132.3M $15.37M $131.7M $58.15M $65.07M $58.34M $51.40M
Short-Term Investments $353.2M $252.4M $41.39M $60.12M $45.28M $90.68M $80.66M $84.22M --
Cash & Short-Term Investments $50.25M $21.95M $131.2M $75.49M $176.9M $148.8M $145.7M $142.6M $51.40M
Accounts Receivable, Net $52K $0 $294K $4.70M -- -- -- -- --
Other Current Assets $86K $355K $0 -- -- -- -- -- --
Total Current Assets $409.4M $280.9M $177.5M $82.03M $180.7M $151.5M $149.8M $145.3M $52.50M
Property, Plant & Equipment, Net $296K $194K $185K $142K $7.46M $8.31M $9.89M $10.21M $1.96M
Long-Term Investments $110.1M $81.73M $0 -- -- -- -- -- --
Other Non-Current Assets -- -- -- -- -- -- -- -- $4.0K
Total Non-Current Assets $121.5M $93.10M $1.95M $1.08M $9.24M $10.09M $11.67M $11.99M $1.96M
Total Assets $530.9M $374.0M $179.4M $83.11M $189.9M $161.6M $161.5M $157.3M $54.46M
Accounts Payable $9.72M $4.58M $2.61M $1.17M $3.04M $3.76M $2.81M $3.49M $167K
Deferred Revenue (Current) $1.19M $479K $0 $100K -- -- -- -- --
Total Current Liabilities $30.73M $18.45M $9.63M $8.22M $10.86M $11.43M $14.12M $10.42M $4.14M
Deferred Revenue (Non-Current) $5.77M $1.91M $0 $791K -- -- -- -- --
Total Non-Current Liabilities $6.79M $3.08M $904K $1.23M $6.40M $6.28M $6.21M $1.25M $0
Total Liabilities $37.52M $21.53M $10.54M $9.45M $17.26M $17.71M $20.32M $11.66M $4.14M
Total Debt (incl. Leases) $1.39M $1.49M $585K $29.96M -- -- -- -- --
Common Stock $43K $31K $15K $0 $59K $49K $39K $33K $2.0K
Retained Earnings -$336.7M -$174.4M -$89.42M -$45.87M -$325.6M -$254.4M -$179.5M -$102.7M -$45.21M
Accumulated Other Comp. Income $489K $106K $47K -$161K -$30K -$23K $8.0K -$8.0K --
Total Stockholders' Equity $493.4M $352.5M $168.9M -$44.37M -$17.25M $143.9M $141.2M $145.6M -$42.12M
Total Equity $493.4M $352.5M $168.9M -$44.37M -$17.25M $143.9M $141.2M $145.6M -$42.12M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $55.69M $110.5M $627.7M $51.09M $55.98M $13.24M $10.12M $22.79M
Short-Term Investments $782.1M $776.3M $483.6M $353.2M $346.6M $244.2M $253.1M $252.4M
Cash & Short-Term Investments $54.08M $107.6M $617.1M $50.25M $54.99M $11.95M $9.25M $21.95M
Accounts Receivable, Net $582K $106K $1.23M $52K $5.00M $39K $1.00M $0
Other Current Assets $169K $184K $83K $86K $73K $111K $392K $355K
Total Current Assets $856.0M $897.5M $1.12B $409.4M $413.8M $263.6M $271.0M $280.9M
Property, Plant & Equipment, Net $749K $418K $274K $296K $185K $207K $191K $194K
Long-Term Investments $406.0M $303.6M $113.9M $110.1M $152.9M $51.70M $68.31M $81.73M
Total Non-Current Assets $420.2M $315.7M $127.0M $121.5M $163.6M $62.47M $77.58M $93.10M
Total Assets $1.28B $1.21B $1.25B $530.9M $577.4M $326.1M $348.6M $374.0M
Accounts Payable $5.50M $6.39M $5.27M $9.72M $6.71M $5.40M $8.27M $4.58M
Deferred Revenue (Current) $1.59M $1.52M $1.49M $1.19M $954K $479K $479K $479K
Total Current Liabilities $28.52M $34.39M $38.28M $30.73M $23.86M $20.09M $16.95M $18.45M
Deferred Revenue (Non-Current) $5.45M $5.94M $6.32M $5.77M $6.07M $1.78M $1.85M $1.91M
Total Non-Current Liabilities $6.31M $6.86M $7.29M $6.79M $7.14M $2.90M $3.02M $3.08M
Total Liabilities $34.82M $41.25M $45.57M $37.52M $30.99M $23.00M $19.97M $21.53M
Total Debt (incl. Leases) $1.21M $1.29M $1.36M $1.39M $1.28M $1.33M $1.40M $1.49M
Common Stock $56K $55K $54K $43K $43K $32K $32K $31K
Retained Earnings -$474.4M -$427.8M -$377.6M -$336.7M -$272.3M -$235.5M -$203.9M -$174.4M
Accumulated Other Comp. Income -$6.28M -$2.13M -$575K $489K $163K $98K $270K $106K
Total Stockholders' Equity $1.24B $1.17B $1.20B $493.4M $546.5M $303.1M $328.6M $352.5M
Total Equity $1.24B $1.17B $1.20B $493.4M $546.5M $303.1M $328.6M $352.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$162.3M -$84.97M -$43.55M -$28.48M -$71.14M -$74.94M -$76.77M -$57.52M -$35.49M -$9.43M
Depreciation & Amortization $111K $96K $67K $1.93M $2.02M $1.98M $1.84M $875K $376K $6.0K
Stock-Based Compensation $22.79M $12.89M $2.90M $1.52M $10.31M $9.94M $10.00M $10.70M $2.26M $662K
Change in Receivables -$52K $0 -- -- -- -- -- -- -- --
Change in Payables -- -- -- -$801K -$720K $948K $145K $2.50M -$1.12M $1.01M
Operating Cash Flow -$129.1M -$78.18M -$36.86M -$29.07M -$59.53M -$64.02M -$57.10M -$41.89M -$22.26M -$6.53M
Capital Expenditure -- -- -- -$314K -$1.26M -$400K -$3.06M -$7.67M -$2.20M -$139K
Free Cash Flow -- -- -- -$29.38M -$60.80M -$64.42M -$60.16M -$49.56M -$24.46M -$6.67M
Purchases of Investments -$435.0M -$413.7M -$57.42M -$69.50M -$45.31M -$95.73M -$144.4M -$84.04M -- --
Investing Cash Flow -$122.8M -$286.8M $20.25M -$59.82M $43.43M -$10.63M $1.53M -$91.70M -$2.20M -$139K
Common Stock Issued $317K $0 $0 $2.90M $0 $64.86M $60.87M $93.00M -- --
Financing Cash Flow $280.1M $255.6M $133.6M $96.68M $89.60M $67.74M $62.30M $142.1M $71.49M $10.71M
Net Change in Cash $28.23M -$109.4M $117.0M $7.79M $73.50M -$6.92M $6.73M $8.56M $47.02M $4.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$46.64M -$50.22M -$40.83M -$64.43M -$36.77M -$31.63M -$29.51M -$28.44M
Depreciation & Amortization $37K $37K $32K $27K $27K $30K $27K $26K
Stock-Based Compensation $12.72M $11.90M $10.60M $5.98M $5.79M $5.71M $5.32M $3.92M
Change in Receivables -$476K $1.12M -$1.18M $4.95M -$4.96M $961K -$1.00M $0
Operating Cash Flow -$50.33M -$48.98M -$28.86M -$46.98M -$30.55M -$23.89M -$27.63M -$27.44M
Purchases of Investments -$323.1M -$565.8M -$238.6M -$54.73M -$279.8M -$33.11M -$67.32M -$108.1M
Investing Cash Flow -$111.9M -$478.5M -$134.0M $37.20M -$201.3M $26.45M $14.79M -$23.11M
Common Stock Issued $244K $0 $120K $1.0K $187K $0 $129K $0
Financing Cash Flow $107.5M $10.38M $739.4M $4.88M $274.5M $568K $161K $39.68M
Net Change in Cash -$54.73M -$517.1M $576.6M -$4.90M $42.68M $3.12M -$12.68M -$10.88M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -8739.3% -1633.7% -1704.7% -- -- -- -- -- -- --
Net Profit Margin -7973.3% -1362.8% -1541.2% -- -- -- -- -- -- --
Return on Equity (ROE) -32.9% -24.1% -25.8% -- -- -52.1% -54.4% -39.5% -- --
Return on Assets (ROA) -30.6% -22.7% -24.3% -34.3% -37.5% -46.4% -47.5% -36.6% -65.2% --
Current Ratio 13.32x 15.22x 18.42x 9.97x 16.63x 13.26x 10.62x 13.95x 12.68x --
Quick Ratio 1.64x 1.19x 13.65x 9.75x 16.29x 13.02x 10.32x 13.68x 12.41x --
Debt to Equity 0.00x 0.00x 0.00x -- -- -- -- -- -- --
Revenue Growth (YoY) -67.3% +120.6% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -8739.3% -4558.4% -2676.6% -1796.4% -1633.7%
Net Profit Margin -- -- -- -7973.3% -4104.8% -2364.1% -1544.0% -1362.8%
Return on Equity (ROE) -16.3% -16.4% -14.5% -32.9% -23.1% -37.9% -30.7% -24.1%
Return on Assets (ROA) -15.8% -15.8% -13.9% -30.6% -21.9% -35.2% -28.9% -22.7%
Current Ratio 30.02x 26.10x 29.25x 13.32x 17.35x 13.12x 15.99x 15.22x
Quick Ratio 1.92x 3.13x 16.15x 1.64x 2.51x 0.60x 0.60x 1.19x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -- -- -- -78.6% -81.8% -89.6% +33.1% --
Source: SEC EDGAR CompanyFacts (CIK 0001690585) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:16 UTC · Open in terminal